Sage Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSage Therapeutics

Sage Therapeutics(SAGE)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Apomorphine	Apomorphine	2022-02-23	2023-2036	Parkinson disease , Erectile dysfunction
Chlorhexidine	Chlorhexidine	2005-04-25	2024-2027	Periodontal diseases , Infectious skin diseases , Gram-negative bacterial infections , Oral candidiasis , Gram-positive bacterial infections , Hypercholesterolemia , Coronary artery disease , Hypertriglyceridemia , Hyperlipoproteinemias
Zulresso	Brexanolone	2019-06-17	2029-2037	Postpartum depression

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

psychotic disorders

,

mental disorders

,

,

alcohol drinking

,

essential tremor

,

,

,

status epilepticus

,

,

respiratory distress syndrome

,

acute lung injury

,

newborn respiratory distress syndrome

,

,

postpartum depression

,

,

depressive disorder

,

post-traumatic stress disorders

,

traumatic stress disorders

Chlorhexidine gluconate

breast neoplasms

,

non-small-cell lung carcinoma

,

,

,

communicable diseases

breast neoplasms

,

non-small-cell lung carcinoma

,

,

,

communicable diseases

stomach neoplasms

,

esophageal neoplasms

Cetylpyridinium chloride

,

Sodium chloride

healthy volunteers/patients

breast neoplasms

,

inflammatory breast neoplasms

actinic keratosis

,

healthy volunteers/patients

,

diabetic nephropathies

,

kidney diseases

,

liver cirrhosis

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

non-alcoholic fatty liver disease

,

breast neoplasms

,

head and neck neoplasms

,

,

,

glandular and epithelial neoplasms

,

healthy volunteers/patients

,

,

clostridium infections

,

clostridioides difficile

,

,

postoperative pain

,

,

drug resistant epilepsy

,

consciousness disorders

,

general anesthesia

type 2 diabetes mellitus

,

diabetes mellitus

,

movement disorders

,

psychomotor agitation

,

drug-induced akathisia

,

migraine disorders

,

,

,

,

urinary tract infections

,

clostridium infections

,

,

communicable diseases

,

surgical wound infection

,

cross infection

,

postoperative complications

,

staphylococcal infections

,

ventilator-associated pneumonia

,

,

methicillin-resistant staphylococcus aureus

,

infectious skin diseases

,

,

soft tissue infections

,

,

,

,

urinary tract infections

,

clostridium infections

,

,

communicable diseases

,

surgical wound infection

,

cross infection

,

postoperative complications

,

staphylococcal infections

,

ventilator-associated pneumonia

,

,

methicillin-resistant staphylococcus aureus

,

infectious skin diseases

,

,

soft tissue infections

,

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use